Iron overload alters innate and T helper cell responses to Candida albicans in mice

The Journal of Infectious Diseases
A MencacciL Romani

Abstract

The effect of iron overload on susceptibility of mice to Candida albicans infection and on the type of T helper (Th) immunity elicited was investigated. Iron overload greatly increased susceptibility to disseminated infection with low-virulence C. albicans cells of exogenous origin. The candidacidal activity and the ability to release nitric oxide and bioactive interleukin (IL)-12 were greatly impaired in neutrophils and macrophages from infected mice. CD4 T cells from spleens of iron-overloaded mice were found to produce high levels of IL-4 and IL-10 and low levels of interferon-gamma. Treatment of iron-overloaded mice with the iron chelator, deferoxamine, resulted in the cure of mice from infection, restored the antifungal effector and immunomodulatory functions of the phagocytic cells, and allowed the occurrence of CD4 Th1 protective antifungal responses. These data indicate that iron overload may negatively affect CD4 Th1 development in mice with candidiasis, a function efficiently restored by therapy with deferoxamine.

Citations

Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Thierry SimonartRobert Snoeck
Sep 30, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Bobby J Cherayil
Apr 19, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G S TansarliM E Falagas
Sep 15, 2005·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Igor TheurlGünter Weiss
Sep 14, 2002·Current Infectious Disease Reports·Brad Spellberg, John E. Edwards
Mar 2, 2005·Best Practice & Research. Clinical Haematology·Günter Weiss
Jun 3, 1999·Biochemical Pharmacology·B S Polla
Oct 24, 2003·Disease-a-month : DM·Peter Jacobs, Lucille Wood
Jun 25, 2003·Gynecologic Oncology·Thierry SimonartRobert Snoeck
Feb 14, 2002·Free Radical Biology & Medicine·Hidekazu Tsukamoto
May 22, 2003·Free Radical Biology & Medicine·Akira I HidaShigeru Okada
Oct 1, 1996·Research in Immunology·L RomaniF Bistoni
Aug 1, 1997·Current Opinion in Immunology·L Romani
Dec 3, 1999·Microbes and Infection·G Del SeroL Romani
May 4, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Shih-Ta ShangMing-Yieh Peng
Nov 14, 2012·Nature Reviews. Rheumatology·Günter Weiss, Georg Schett
Mar 20, 1999·Kidney International. Supplement·G Weiss
Nov 14, 2007·The Journal of Experimental Medicine·Marie-France RoyDanielle Malo
Mar 1, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ying ShanHerbert L Bonkovsky
Jun 1, 2005·Surgical Infections·Fredric M Pieracci, Philip S Barie
May 13, 2006·Critical Care Medicine·Fredric M Pieracci, Philip S Barie
Aug 9, 2006·Seminars in Dialysis·Ursula C Brewster
Jul 13, 2004·Gut·C GascheG Weiss
Aug 30, 2011·Blood·Andrew E ArmitageHal Drakesmith
Apr 25, 2006·The Journal of Parasitology·Jacob GolenserPeter Kremsner
Jun 1, 2010·Haematologica·Gianfranca CornaPatrizia Rovere-Querini
Nov 6, 2002·Journal of Neuroimmunology·Roberta BarluzziElisabetta Blasi
Sep 6, 2007·The Journal of Clinical Investigation·Ashraf S IbrahimBrad J Spellberg
Aug 1, 2012·Kidney International Supplements
Sep 13, 2008·Biochimica Et Biophysica Acta·Günter Weiss
Sep 21, 2006·Infectious Disease Clinics of North America·Dimitrios P Kontoyiannis, Russell E Lewis
Jul 12, 2008·Cellular Microbiology·Eugenia Silva-Herzog, Corrella S Detweiler
Nov 11, 2008·European Journal of Immunology·Gernot FritscheGünter Weiss
Sep 14, 2011·Clinical and Experimental Immunology·H MaaziA J M van Oosterhout
Oct 23, 2010·Cellular Microbiology·Manfred NairzGünter Weiss
Dec 18, 2013·Seminars in Dialysis·Julie H Ishida, Kirsten L Johansen
Jun 16, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Yan XuZhonghong Gao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.